5
Population & Baseline Definition Agent
Define baseline populations and cohorts
6
Endpoint Definition Agent
Define and validate trial endpoints
7
Primary Efficacy Analysis Agent
Analyze primary efficacy outcomes
8
Sensitivity & Robustness Analysis Agent
Test robustness of results
9
Subgroup & Responder Identification Agent
Identify responder subgroups
10
Safety & Adverse Event Signal Agent
Detect and characterize safety signals
11
Mechanism & Biomarker Analysis Agent
Analyze biomarkers linked to mechanisms
12
Benefit–Risk Synthesis Agent
Integrate efficacy and safety
14
Protocol Optimization Agent
Suggest protocol refinements
39Temporal Pattern Intelligence
Temporal Safety Signal Evolution Agent
Track how safety signals evolve over time, detecting delayed-onset AEs, time-to-event patterns, and cumulative risk trajectories
41Temporal Pattern Intelligence
Treatment Response Window Optimization Agent
Identify optimal treatment response windows, detecting when patients are most responsive and when treatment adjustments are needed
50Patient Journey Intelligence
Placebo Response Prediction Agent
Predict placebo response patterns, identify high placebo responders, and optimize trial design to minimize placebo effects
54Predictive Prevention Intelligence
Dosing Optimization Intelligence Agent
Identify optimal dosing patterns, detect dose-response relationships, and optimize individual patient dosing
56Cross-Domain Integration Intelligence
Drug-Drug Interaction Discovery Agent
Discover unexpected drug-drug interactions, identify synergistic combinations, and detect interaction patterns
57Cross-Domain Integration Intelligence
Adverse Event Clustering Intelligence Agent
Cluster adverse events into novel patterns, identifying AE syndromes, temporal clusters, and patient-specific AE profiles
60Cross-Domain Integration Intelligence
Long-Term Safety Pattern Detection Agent
Detect long-term safety patterns, identify delayed-onset AEs, and predict cumulative safety risks